Author, Year | Intervention | Dose per day | Treatment duration | Subjects | Method of assessment | Main outcomes | Final effects of specific diet ingredients or nutraceuticals on LDL (number, size and concentration) |
---|---|---|---|---|---|---|---|
Hernáez et al. 2015 [43] | Olive oil | 25 mL/d raw LPCOO; 366 mg/kg or HPCOO; 2.7 mg/kg) | 3 weeks | 25 healthy volunteer men | NMR spectroscopy | HPCOO significantly reduced small LDL particles (− 15.3%), though LPCOO significantly increased small LDL particles (+ 13.6%), differences between groups were significant | Small dense LDL ↓ |
Sialvera et al. 2010 [44] | Phytosterols | 4 g/day | 2 months | 108 metabolic syndrome patients | sLDL e EX “SEIKEN” | Phytosterols supplementation significantly reduced small dense LDL levels (−3.9 mg/dl) in the intervention group compared with the control group | Small dense LDL ↓ |
Garoufi et al. 2014 [45] | Plant sterols | 2 g/day | 6–12 months | 59 hypercholesterolemic and normal children (4.5–15.9 years) | kit (sLDL-EX “SEIKEN” | Plant sterols consumption considerably reduced sdLDL in the intervention group though levels remained higher than control group | Small dense LDL ↓ |
Kratz et al. 2002 [46] | Vegetable oils | Refined olive oil, rapeseed oil, sunflower oil | 4 weeks | 56 healthy adults | PAGE | In response to vegetable oils, LDL size significantly reduced (−0.36 nm) thought differences between groups were not significant. Furthermore, oil consumption did not significantly change LDL size variation | LDL particle size — |
Banuls et al. 2015 [42] | IEB, SB | 4.45 g/day | 12 weeks | 40 healthy adults | PAGE | IEB led to significant elevation in LDL particle size (0.13 nm) compared with baseline and with SB. | LDL particle size ↑ |
Shrestha et al. 2006 [48] 2007 [47] | Treatment cookies, Placebo cookies | Treatment cookies; 7.68 g/d psyllium and 2.6 g/d plant sterols, or Placebo cookies; 0 g psyllium and plant sterols | 3 months | 33 healthy adults | Nongradient, high-resolution PAGE and NMR | psyllium and plant sterols were reduced the medium-small LDL particles (− 18.9 ± 0.7 nmol/L), and considerably increased LDL mean size (+ 0.11 ± 0.04 nm) and LDL peak size (+ 0.2 ± 0.15 nm) in compared with placebo. | Medium-Small LDL particles ↓ LDL particle size ↑ |
Earnest et al. 2007 [49] | Phytosterol esters, canola oil (placebo) | 2.6 g/day | 12 weeks | 54 adults with LDL-C level ≥ 3.33 mmol/L | Relative migration of four plasma standards of known diameter was used to estimate LDL particle size. The estimated diameter for the major peak in each scan was identified as the LDL peak particle size | Proportion of LDL, mean and peak LDL particle sizes did not change in both groups. | LDL particle size — |
Matvienko et al. 2002 [50] | Ground beef with phytosterols, Control (ground beef alone) | 2.7 g of phytosterols | 4 weeks | 34 men with elevated plasma TC and LDL cholesterol | Nondenaturing PAGE and NMR | No significant change in small LDL particle and LDL peak particle size. However, mean LDL particle number decreased than control. | Small dense LDL — LDL particle size — LDL particle number ↓ |
Theuwissen et al. 2009 [51] | Stanol supplementation | 2.5 g/day of plant stanols | 3 weeks | 28 adults with elevated triacylglycerols | NMR by Liposcience | After stanol supplementation the number of total LDL particles decreased, but sdLDL particles did not significantly change compared with baseline. | Small dense LDL — LDL particle number ↓ |
Utarwuthipong et al. 2009 [52] | SBO; RBO; PO; mixture of (3:1) RBO/PO | 20% of total energy as SBO; 20% of total energy as RBO; 20% of total energy as PO; 20% of total energy as mixture of (3:1) RBO/PO. | 10 weeks | 16 hypercholesterolemia women | Sequential ultracentrifugation technique | SBO and RBO/PO significantly reduced sdLDL-cholesterol level (− 10%) and (− 5%) respectively, though PO significantly increased sdLDL-cholesterol level (+ 5%) and RBO was not significantly varied, differences between groups were significant. | Small dense LDL ↓ |